The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...

Persistent cold hands could signal Peripheral Artery Disease PAD linked to high cholesterol Learn symptoms risk factors complications and prevention tips ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...

The Delhi High Court recently underscored the importance of disability pension for soldiers who suffer the stresses and ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Commonwealth Equity Services LLC decreased its holdings in Koninklijke Philips (NYSE:PHG – Free Report) by 17.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 55,787 shares of the ...